Respiratory infections

State of the art session
Chairs: D. Stolz (Basel, Switzerland), T. Welte (Hannover, Germany)
Aims: To review the challenges and opportunities in respiratory infections, including antibiotics for pneumonia, bronchiectasis, antibiotic resistance and challenges for the upcoming decade; to discuss the available evidence and more recent recommendations regarding treatment and prevention of tuberculosis (TB).

Bronchiectasis: state-of-the-art diagnostic and therapeutic approaches A. Shoemark (Dundee (Angus), United Kingdom)
Antibiotic resistance in respiratory infections: challenges and actions for the upcoming decade M. Shteinberg (Haifa, Israel)
Has the time come to shorten TB treatment and TB preventive therapy? C. Magis-Escurra (Nijmegen, Netherlands)
The challenges of severe pneumonia: new pathogens, new drugs and new formulations M. Niederman (New York, United States of America)
Discussion and Q&A